Next Gen Research Fellowship

Next Gen Research Fellowship

Founded in 2023, our Next Generation Cancer Research Fellowships mark a new era of cancer research at Cancer Council Queensland. 

Replacing the ACCR grants scheme, these fellowships fund early career cancer researchers who are on the front-line of clinical innovations in cancer detection and treatment. 

Fund local research, make global breakthroughs

“They will come up with new knowledge and new knowledge leads to better ways of dealing with patient health problems or problems of the world at large.” Emeritus Professor Ian Frazer

Partner with Cancer Council Queensland and help us fund the brightest minds in cancer research. Your investment funds local research and to make global breakthroughs by directly funding early career cancer researchers who are on the front-line of clinical innovations in cancer detection and treatment.

In addition to making the next big breakthrough possible, your contribution will also be recognised with: 

  • Exclusive co-branding and naming rights for one of four fellowships awarded each year 
  • Promotional and PR opportunities as the research activity progresses 
  • Ongoing exclusive research updates directly from the research team you are funding 

Please contact our Philanthropy Team today at donorrelations@cancerqld.org.au or call 1300 663 936.

Meet the 2024 Next Generation Cancer Research Fellowship recipients


Dr Mostafa Kamal MasudDr. Masud, from The University of Queensland, is conducting research focused on developing a device which, using nanoengineered structures, aims to make it possible to detect early-stage ovarian cancer within 2 hours at a GP clinic.

Dr. Masud, from The University of Queensland, is conducting research focused on developing a device which, using nanoengineered structures, aims to make it possible to detect early-stage ovarian cancer within 2 hours at a GP clinic.

Learn more

 



Dr Jasmin StraubeDr. Jasmin Straube from QIMR Berghofer is researching vulnerabilities in leukemic stem cells carrying poor prognostic mutations. Her work will play a critical role in improving outcomes for patients with myeloid blood cancer.

Dr. Jasmin Straube from QIMR Berghofer is researching vulnerabilities in leukemic stem cells carrying poor prognostic mutations. Her work will play a critical role in improving outcomes for patients with myeloid blood cancer.

Learn more

 



Dr Mathias SeviiriDr. Mathias Seviiri, also from QIMR Berghofer, is tackling the complex landscape of skin cancer. His research aims to unravel the complex relationships between genetics, treatment responses, and adverse events in patients undergoing treatment for melanoma and keratinocyte cancers.

Dr. Mathias Seviiri, also from QIMR Berghofer, is tackling the complex landscape of skin cancer. His research aims to unravel the complex relationships between genetics, treatment responses, and adverse events in patients undergoing treatment for melanoma and keratinocyte cancers.

Learn more